相关实验视频
Updated: Mar 9, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
超越爆发:一种传播结核病和血栓形成的病例,伪装成IBD恶化
Germán Ramírez-Olivencia1, Celia Caravaca2, Marta Sanz Alba3
1Faculty of Medicine, Department of Medicine, HLIU and CBRN Infectious Diseases Unit, Gómez Ulla Central Defense Hospital (CSVE), University of Alcalá, Glorieta del Ejército S/N, 28047, Madrid, Spain. german.ramirez@uah.es.
在接受抗瘤坏死因子α (抗TNFα) 治疗的炎症性肠病 (IBD) 患者中诊断感染具有挑战性. 这一案例突出了模仿IBD爆发的传播性结核病,强调了免疫抑制患者需要广泛差异的需要.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 在接受抗瘤坏死因子α (抗TNFα) 治疗的患者中,区分炎症性肠病 (IBD) 爆发与机会性感染至关重要.
- 与抗TNFα药物相关的免疫抑制增加了对感染的易感性,使诊断复杂化.
研究的目的:
- 报告在接受阿达利穆马布治疗的患者中模仿IBD爆发的传播性结核病 (TB) 病例.
- 突出诊断挑战和考虑在免疫抑制IBD患者的机会性感染的重要性.
主要方法:
- 一份病例报告显示,一名54岁的克罗恩氏病患者接受了阿达利木马布治疗,出现了暗示IBD爆发的症状.
- 诊断工作包括计算机断层扫描 (CT),聚合酶链反应 (PCR) 和支气管支气管洗的培养,以及淋巴结组织病理学.
- 治疗包括皮质类固醇,抗生素,抗结核疗法和抗凝药.
主要成果:
- 这位患者出现了肠炎,中腔淋巴腺病和下静脉血栓,最初被怀疑是IBD爆发.
- 通过PCR和来自支气管支气管洗和淋巴结活检的培养证实了传播性结核病.
- 用抗结核疗法和抗凝固药物治疗的成功导致在停止服用阿达利木马布后的临床改善.
结论:
- 机会性感染,如传播性结核病,可以在免疫抑制患者中呈现异常并模仿IBD爆发.
- 高可疑指数和侵入性诊断对于确认感染至关重要,特别是当有系统性症状或血栓形成时.
- 停止抗TNFα治疗和适当的抗微生物治疗对于管理这种并发症至关重要.
更多相关视频
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...